Atlas Trials

A Multi-Center, Non-Controlled Clinical Study of Sorafenib Adjuvant Therapy in Advanced Renal-Cell Carcinoma

Clinical trial NCT01041482 · UNKNOWN

Trial details

NCT number
NCT01041482
Sponsor
Chinese Academy of Medical Sciences
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Renal Cell Carcinoma
Start date
2008-11-01
Primary completion
2011-11-01
Enrollment
140

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.